Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Sévenet N"" wg kryterium: Autor


Tytuł :
Prostate cancer and PARP inhibitors: progress and challenges.
Autorzy :
Teyssonneau D; Department of Medical Oncology, Institut Bergonie, Bordeaux, France. .
Margot H; Department of Genetic, Institut Bergonie, Bordeaux, France.
Cabart M; Department of Medical Oncology, Institut Bergonie, Bordeaux, France.
Anonnay M; Department of Medical Oncology, Institut Bergonie, Bordeaux, France.
Sargos P; Department of Radiotherapy, Institut Bergonie, Bordeaux, France.
Vuong NS; Department of Urology, Clinique Saint-Augustin, Bordeaux, France.
Soubeyran I; Department of Biopathology, Institut Bergonie, Bordeaux, France.
Sevenet N; Department of Genetic, Institut Bergonie, Bordeaux, France.
Roubaud G; Department of Medical Oncology, Institut Bergonie, Bordeaux, France.
Pokaż więcej
Źródło :
Journal of hematology & oncology [J Hematol Oncol] 2021 Mar 29; Vol. 14 (1), pp. 51. Date of Electronic Publication: 2021 Mar 29.
Typ publikacji :
Journal Article; Review
Czasopismo naukowe
Tytuł :
Concordance between Tumor and Germline BRCA Status in High-Grade Ovarian Carcinoma Patients in the Phase III PAOLA-1/ENGOT-ov25 Trial.
Autorzy :
Callens C; Genetics Department, Institut Curie and Paris Sciences Lettres University, Paris, France.
Vaur D; Laboratoire de Biologie Clinique et Oncologique, Centre François Baclesse, Caen, France.
Soubeyran I; Biopathology Department, Institut Bergonié, Bordeaux, France.
Rouleau E; Biopathology Department, Institut Gustave Roussy, Université Paris-Saclay, Villejuif, France.
Just PA; Department of Pathological Anatomy and Cytology, Hôpital Cochin, Assistance Publique - Hôpitaux de Paris, Paris, France.
Guillerm E; Department of Pathological Anatomy and Cytology, Hôpital Cochin, Assistance Publique - Hôpitaux de Paris, Paris, France.
Golmard L; Genetics Department, Institut Curie and Paris Sciences Lettres University, Paris, France.
Goardon N; Laboratoire de Biologie Clinique et Oncologique, Centre François Baclesse, Caen, France.
Sevenet N; Biopathology Department, Institut Bergonié, Bordeaux, France.
Cabaret O; Biopathology Department, Institut Gustave Roussy, Université Paris-Saclay, Villejuif, France.
Harter P; Kliniken Essen Mitte, Essen, AGO De, Germany.
Gonzalez-Martin A; Clínica Universidad de Navarra, Madrid, formerly MD Anderson Cancer Center, Madrid, GEICO, Spain.
Fujiwara K; Saitama Medical University, Saitama, GOTIC, Japan.
Cecere SC; Department of Urology and Gynecology, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Napoli, MITO Italy.
Colombo N; European Institute of Oncology, Milan, MANGO Italy.
Marth C; Medical University of Innsbruck, AGO Au, Austria.
Vergote I; University Hospital Leuven, Department of Gynecologic oncology, Leuven Cancer Institute, Leuven, BGOG, Belgium.
Maenpaa J; Tampere University and University Hospital Cancer Centre, Tampere, NSGO, Finland.
Pujade-Lauraine E; ARCAGY Research, Paris, France.
Ray-Coquard I; Centre Léon Bérard and University, Claude Bernard Lyon 1, Lyon, GINECO, France.
Pokaż więcej
Źródło :
Journal of the National Cancer Institute [J Natl Cancer Inst] 2020 Dec 29. Date of Electronic Publication: 2020 Dec 29.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Novel diagnostic tool for prediction of variant spliceogenicity derived from a set of 395 combined in silico/in vitro studies: an international collaborative effort.
Autorzy :
Leman R; Laboratoire de Biologie Clinique et Oncologique, Centre François Baclesse, 14000 Caen, France.; Inserm U1245 Genomics and Personalized Medecine in Cancer and Neurological Disorders, Normandie Univ, UNIROUEN, Normandy Centre for Genomic and Personalized Medicine, 76031 Rouen, France.; Normandie Univ, UNICAEN, 14000 Caen, France.
Gaildrat P; Inserm U1245 Genomics and Personalized Medecine in Cancer and Neurological Disorders, Normandie Univ, UNIROUEN, Normandy Centre for Genomic and Personalized Medicine, 76031 Rouen, France.
Le Gac G; Inserm UMR1078, Genetics, Functional Genomics and Biotechnology, Université de Bretagne Occidentale, 29200 Brest, France.
Ka C; Inserm UMR1078, Genetics, Functional Genomics and Biotechnology, Université de Bretagne Occidentale, 29200 Brest, France.
Fichou Y; Inserm UMR1078, Genetics, Functional Genomics and Biotechnology, Université de Bretagne Occidentale, 29200 Brest, France.
Audrezet MP; Inserm UMR1078, Genetics, Functional Genomics and Biotechnology, Université de Bretagne Occidentale, 29200 Brest, France.
Caux-Moncoutier V; Inserm U830, Institut Curie Centre de Recherches, 75005 Paris, France.; Université Paris Descartes, Sorbonne Paris Cité, 75005 Paris, France.; Service de Génétique, Institut Curie, 75005 Paris, France.
Caputo SM; Service de Génétique, Institut Curie, 75005 Paris, France.
Boutry-Kryza N; Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Hospices Civils de Lyon, 69000 Lyon, France.
Léone M; Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Hospices Civils de Lyon, 69000 Lyon, France.
Mazoyer S; Lyon Neuroscience Research Center-CRNL, Inserm U1028, CNRS UMR 5292, University of Lyon, 69008 Lyon, France.
Bonnet-Dorion F; Inserm U916, Département de Pathologie, Laboratoire de Génétique Constitutionnelle, Institut Bergonié, 33000 Bordeaux, France.
Sevenet N; Inserm U916, Département de Pathologie, Laboratoire de Génétique Constitutionnelle, Institut Bergonié, 33000 Bordeaux, France.
Guillaud-Bataille M; Gustave Roussy, Université Paris-Saclay, Département de Biopathologie, 94805 Villejuif, France.
Rouleau E; Gustave Roussy, Université Paris-Saclay, Département de Biopathologie, 94805 Villejuif, France.
Bressac-de Paillerets B; Gustave Roussy, Université Paris-Saclay, Département de Biopathologie, 94805 Villejuif, France.
Wappenschmidt B; Division of Molecular Gynaeco-Oncology, Department of Gynaecology and Obstetrics, University Hospital of Cologne, 50937 Cologne, Germany.
Rossing M; Centre for Genomic Medicine, Rigshospitalet, University of Copenhagen, 1017 Copenhagen, Denmark.
Muller D; Laboratoire d'Oncogénétique, Centre Paul Strauss, 67000 Strasbourg, France.
Bourdon V; Laboratoire d'Oncogénétique Moléculaire, Institut Paoli-Calmettes, 13009 Marseille, France.
Revillon F; Laboratoire d'Oncogénétique Moléculaire Humaine, Centre Oscar Lambret, 59000 Lille, France.
Parsons MT; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, 4006 Herston, Queensland, Australia.
Rousselin A; Laboratoire de Biologie Clinique et Oncologique, Centre François Baclesse, 14000 Caen, France.; Inserm U1245 Genomics and Personalized Medecine in Cancer and Neurological Disorders, Normandie Univ, UNIROUEN, Normandy Centre for Genomic and Personalized Medicine, 76031 Rouen, France.
Davy G; Laboratoire de Biologie Clinique et Oncologique, Centre François Baclesse, 14000 Caen, France.; Inserm U1245 Genomics and Personalized Medecine in Cancer and Neurological Disorders, Normandie Univ, UNIROUEN, Normandy Centre for Genomic and Personalized Medicine, 76031 Rouen, France.
Castelain G; Inserm U1245 Genomics and Personalized Medecine in Cancer and Neurological Disorders, Normandie Univ, UNIROUEN, Normandy Centre for Genomic and Personalized Medicine, 76031 Rouen, France.
Castéra L; Laboratoire de Biologie Clinique et Oncologique, Centre François Baclesse, 14000 Caen, France.; Inserm U1245 Genomics and Personalized Medecine in Cancer and Neurological Disorders, Normandie Univ, UNIROUEN, Normandy Centre for Genomic and Personalized Medicine, 76031 Rouen, France.
Sokolowska J; Service de Génétique, CHU Nancy, 54035 Nancy, France.
Coulet F; Service de génétique, Hôpital Pitié Salpétrière, AP-HP, 75013 Paris, France.
Delnatte C; Laboratoire de génétique moléculaire, CHU Nantes, 44000 Nantes, France.
Férec C; Inserm UMR1078, Genetics, Functional Genomics and Biotechnology, Université de Bretagne Occidentale, 29200 Brest, France.
Spurdle AB; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, 4006 Herston, Queensland, Australia.
Martins A; Inserm U1245 Genomics and Personalized Medecine in Cancer and Neurological Disorders, Normandie Univ, UNIROUEN, Normandy Centre for Genomic and Personalized Medicine, 76031 Rouen, France.
Krieger S; Laboratoire de Biologie Clinique et Oncologique, Centre François Baclesse, 14000 Caen, France.; Inserm U1245 Genomics and Personalized Medecine in Cancer and Neurological Disorders, Normandie Univ, UNIROUEN, Normandy Centre for Genomic and Personalized Medicine, 76031 Rouen, France.; Normandie Univ, UNICAEN, 14000 Caen, France.
Houdayer C; Inserm U830, Institut Curie Centre de Recherches, 75005 Paris, France.; Université Paris Descartes, Sorbonne Paris Cité, 75005 Paris, France.; Service de Génétique, Institut Curie, 75005 Paris, France.
Pokaż więcej
Źródło :
Nucleic acids research [Nucleic Acids Res] 2020 Feb 20; Vol. 48 (3), pp. 1600-1601.
Typ publikacji :
Journal Article; Published Erratum
Czasopismo naukowe
Tytuł :
Corrigendum: Novel diagnostic tool for prediction of variant spliceogenicity derived from a set of 395 combined in silico/in vitro studies: an international collaborative effort.
Autorzy :
Leman R; Laboratoire de Biologie Clinique et Oncologique, Centre François Baclesse, 14000 Caen, France.; Inserm U1245 Genomics and Personalized Medecine in Cancer and Neurological Disorders, Normandie Univ, UNIROUEN, Normandy Centre for Genomic and Personalized Medicine, 76031 Rouen, France.; Normandie Univ, UNICAEN, 14000 Caen, France.
Gaildrat P; Inserm U1245 Genomics and Personalized Medecine in Cancer and Neurological Disorders, Normandie Univ, UNIROUEN, Normandy Centre for Genomic and Personalized Medicine, 76031 Rouen, France.
Gac GL; Inserm UMR1078, Genetics, Functional Genomics and Biotechnology, Université de Bretagne Occidentale, 29200 Brest, France.
Ka C; Inserm UMR1078, Genetics, Functional Genomics and Biotechnology, Université de Bretagne Occidentale, 29200 Brest, France.
Fichou Y; Inserm UMR1078, Genetics, Functional Genomics and Biotechnology, Université de Bretagne Occidentale, 29200 Brest, France.
Audrezet MP; Inserm UMR1078, Genetics, Functional Genomics and Biotechnology, Université de Bretagne Occidentale, 29200 Brest, France.
Caux-Moncoutier V; Inserm U830, Institut Curie Centre de Recherches, 75005 Paris, France.; Université Paris Descartes, Sorbonne Paris Cité, 75005 Paris, France.; Service de Génétique, Institut Curie, 75005 Paris, France.
Caputo SM; Service de Génétique, Institut Curie, 75005 Paris, France.
Boutry-Kryza N; Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Hospices Civils de Lyon, 69000 Lyon, France.
Léone M; Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Hospices Civils de Lyon, 69000 Lyon, France.
Mazoyer S; Lyon Neuroscience Research Center-CRNL, Inserm U1028, CNRS UMR 5292, University of Lyon, 69008 Lyon, France.
Bonnet-Dorion F; Inserm U916, Département de Pathologie, Laboratoire de Génétique Constitutionnelle, Institut Bergonié, 33000 Bordeaux, France.
Sevenet N; Inserm U916, Département de Pathologie, Laboratoire de Génétique Constitutionnelle, Institut Bergonié, 33000 Bordeaux, France.
Guillaud-Bataille M; Gustave Roussy, Université Paris-Saclay, Département de Biopathologie, 94805 Villejuif, France.
Rouleau E; Gustave Roussy, Université Paris-Saclay, Département de Biopathologie, 94805 Villejuif, France.
Paillerets BB; Gustave Roussy, Université Paris-Saclay, Département de Biopathologie, 94805 Villejuif, France.
Wappenschmidt B; Division of Molecular Gynaeco-Oncology, Department of Gynaecology and Obstetrics, University Hospital of Cologne, 50937 Cologne, Germany.
Rossing M; Centre for Genomic Medicine, Rigshospitalet, University of Copenhagen, 1017 Copenhagen, Denmark.
Muller D; Laboratoire d'Oncogénétique, Centre Paul Strauss, 67000 Strasbourg, France.
Bourdon V; Laboratoire d'Oncogénétique Moléculaire, Institut Paoli-Calmettes, 13009 Marseille, France.
Revillon F; Laboratoire d'Oncogénétique Moléculaire Humaine, Centre Oscar Lambret, 59000 Lille, France.
Parsons MT; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, 4006 Herston, Queensland, Australia.
Rousselin A; Laboratoire de Biologie Clinique et Oncologique, Centre François Baclesse, 14000 Caen, France.; Inserm U1245 Genomics and Personalized Medecine in Cancer and Neurological Disorders, Normandie Univ, UNIROUEN, Normandy Centre for Genomic and Personalized Medicine, 76031 Rouen, France.
Davy G; Laboratoire de Biologie Clinique et Oncologique, Centre François Baclesse, 14000 Caen, France.; Inserm U1245 Genomics and Personalized Medecine in Cancer and Neurological Disorders, Normandie Univ, UNIROUEN, Normandy Centre for Genomic and Personalized Medicine, 76031 Rouen, France.
Castelain G; Inserm U1245 Genomics and Personalized Medecine in Cancer and Neurological Disorders, Normandie Univ, UNIROUEN, Normandy Centre for Genomic and Personalized Medicine, 76031 Rouen, France.
Castéra L; Laboratoire de Biologie Clinique et Oncologique, Centre François Baclesse, 14000 Caen, France.; Inserm U1245 Genomics and Personalized Medecine in Cancer and Neurological Disorders, Normandie Univ, UNIROUEN, Normandy Centre for Genomic and Personalized Medicine, 76031 Rouen, France.
Sokolowska J; Service de Génétique, CHU Nancy, 54035 Nancy, France.
Coulet F; Service de génétique, Hôpital Pitié Salpétrière, AP-HP, 75013 Paris, France.
Delnatte C; Laboratoire de génétique moléculaire, CHU Nantes, 44000 Nantes, France.
Férec C; Inserm UMR1078, Genetics, Functional Genomics and Biotechnology, Université de Bretagne Occidentale, 29200 Brest, France.
Spurdle AB; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, 4006 Herston, Queensland, Australia.
Martins A; Inserm U1245 Genomics and Personalized Medecine in Cancer and Neurological Disorders, Normandie Univ, UNIROUEN, Normandy Centre for Genomic and Personalized Medicine, 76031 Rouen, France.
Krieger S; Laboratoire de Biologie Clinique et Oncologique, Centre François Baclesse, 14000 Caen, France.; Inserm U1245 Genomics and Personalized Medecine in Cancer and Neurological Disorders, Normandie Univ, UNIROUEN, Normandy Centre for Genomic and Personalized Medicine, 76031 Rouen, France.; Normandie Univ, UNICAEN, 14000 Caen, France.
Houdayer C; Inserm U830, Institut Curie Centre de Recherches, 75005 Paris, France.; Université Paris Descartes, Sorbonne Paris Cité, 75005 Paris, France.; Service de Génétique, Institut Curie, 75005 Paris, France.
Pokaż więcej
Źródło :
Nucleic acids research [Nucleic Acids Res] 2018 Nov 30; Vol. 46 (21), pp. 11656-11657.
Typ publikacji :
Journal Article; Published Erratum
Czasopismo naukowe
Tytuł :
Analysis of the expression of cell cycle regulators in Ewing cell lines: EWS-FLI-1 modulates p57KIP2and c-Myc expression.
Autorzy :
Dauphinot L; INSERM U509, Laboratoire de Pathologie Moléculaire des Cancers, Institut Curie, 26 rue d'Ulm, 75248 Paris Cedex 05, France.
De Oliveira C
Melot T
Sevenet N
Thomas V
Weissman BE
Delattre O
Pokaż więcej
Źródło :
Oncogene [Oncogene] 2001 May 31; Vol. 20 (25), pp. 3258-65.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Cell Cycle Proteins/*metabolism
Nuclear Proteins/*metabolism
Oncogene Proteins, Fusion/*metabolism
Proto-Oncogene Proteins c-myc/*metabolism
Sarcoma, Ewing/*etiology
Transcription Factors/*metabolism
Base Sequence ; Cell Cycle ; Cell Transformation, Neoplastic ; Cyclin-Dependent Kinase Inhibitor p57 ; Down-Regulation ; Humans ; Molecular Sequence Data ; Nuclear Proteins/genetics ; Promoter Regions, Genetic ; Proto-Oncogene Protein c-fli-1 ; RNA-Binding Protein EWS ; Tumor Cells, Cultured
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies